The primary antibodies used are as follows: P53 (Proteintech, 60283-2-Ig), pSer46-P53 (CST, 2521), FOXO4 (Proteintech, 21535-1-AP), Ki-67 (D3B5) Rabbit mAb (Alexa Fluor 647 Conjugate) (CST, 12075), P21 (CST, 14074), -H2AX (Abcam, ab2254)
70 HP 150 5-AMINO-1MQ Small-molecule NNMT inhibitor body-composition research ALIASES 5A1MQ, 5-amino-1-methylquinolinium iodide, NNMT inhibitor CLASS Small-molecule NNMT inhibitor (not a peptide) FORMULA C10H11IN2 HALF-LIFE Short plasma half-life (oral bioavailable) ROUTES Oral (in animal studies) Subcutaneous (research) MECHANISM OF ACTION 5-Amino-1-methylquinolinium iodide
For general wellness, monthly injections are often sufficient
(2006) demonstrou uma acelerao significativa da formao do calo sseo em ratos, com mineralizao mais rpida e resistncia mecnica aprimorada